Dexamethasone Prior to Re-treatment With Enzalutamide in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer Previously Treated With Enzalutamide and Docetaxel

NCT02491411 · clinicaltrials.gov ↗

NA

Phase

TERMINATED

Status

5

Enrollment

OTHER

Sponsor class

Stopped The study is terminated due to lower enrollment

Conditions

Hormone-Resistant Prostate Cancer
Metastatic Prostate Carcinoma
Prostate Adenocarcinoma
Stage IV Prostate Cancer

Interventions

DRUG: Dexamethasone
DRUG: Enzalutamide
OTHER: Laboratory Biomarker Analysis
OTHER: Quality-of-Life Assessment

Sponsor

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Collaborators

[object Object]